Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The prognostic value of carcinoembryonic antigen in carcinoma of the prostate.

× No keyword cloud information.

16 in total

1. Carcinoembryonic antigen: current clinical applications.

Authors: S O Freedman
Journal: J Allergy Clin Immunol Date: 1972-12 Impact factor: 10.793

Review 2. The role of immunology in human cancer research.

Authors: P Gold
Journal: Can Med Assoc J Date: 1970-11-07 Impact factor: 8.262

3. Tumor-associated antigen in patients with carcinoma of the colon.

Authors: P Lo Gerfo; F Lo Gerfo; F Herter; H G Barker; H J Hansen
Journal: Am J Surg Date: 1972-02 Impact factor: 2.565

4. Carcinoembryonic antigen in patients with tumors of the urogenital tract.

Authors: G Reynoso; T M Chu; P Guinan; G P Murphy
Journal: Cancer Date: 1972-07 Impact factor: 6.860

5. Demonstration of an antigen common to several varieties of neoplasia.

Authors: P Lo Gerfo; J Krupey; H J Hansen
Journal: N Engl J Med Date: 1971-07-15 Impact factor: 91.245

6. Carcinoembryonic antigen in patients with different cancers.

Authors: G Reynoso; T M Chu; D Holyoke; E Cohen; T Nemoto; J J Wang; J Chuang; P Guinan; G P Murphy
Journal: JAMA Date: 1972-04-17 Impact factor: 56.272

7. Carcinoembryonic antigen (CEA) in inflammatory bowel disease.

Authors: T L Moore; P A Kantrowitz; N Zamcheck
Journal: JAMA Date: 1972-11-20 Impact factor: 56.272

8. The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system.

Authors: D M Thomson; J Krupey; S O Freedman; P Gold
Journal: Proc Natl Acad Sci U S A Date: 1969-09 Impact factor: 11.205

9. Structural studies of the major glycoprotein in preparations with carcinoembryonic antigen activity.

Authors: W D Terry; P A Henkart; J E Coligan; C W Todd
Journal: J Exp Med Date: 1972-07-01 Impact factor: 14.307

10. DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES.

Authors: P GOLD; S O FREEDMAN
Journal: J Exp Med Date: 1965-03-01 Impact factor: 14.307

2 in total

1. Tumour markers in urology: aids in cancer diagnosis and management.

Authors: B Wahren
Journal: Urol Res Date: 1979-06-22

2. Serum tissue polypeptide antigen (TPA) and prostatic acid phosphatase (PAP) in patients with prostatic cancer.

Authors: A Marczyńska; J Kulpa; J Leńko; M Augustyn
Journal: Int Urol Nephrol Date: 1988 Impact factor: 2.370

2 in total